Zhitong Finance App News, Baiyunshan (600332.SH) announced that the company's holding subsidiary Guangzhou Pharmaceutical Co., Ltd. (“Guangzhou Pharmaceutical”) plans to introduce strategic investors and implement targeted stock issuance through public listing on the Guangzhou Property Exchange. The plan is to solicit no more than 15 investors, the issuance price is not less than 3.46 yuan/share, the targeted issuance of no more than 1,734 billion shares, and the scale of capital raised is no more than 6 billion yuan. According to the Guangzhou Pharmaceutical Regulations, companies with this capital increase and stock expansion do not enjoy priority subscription rights.

After the completion of this capital increase and share expansion, it is expected that the company will hold no less than 53.23% of Guangzhou Pharmaceutical's shares. The company is still the controlling shareholder of Guangzhou Pharmaceutical, which will not cause changes in the scope of the company's consolidated statements and will not have a significant adverse impact on the company's production and operation.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.